CMRX Chimerix Inc. Expected Profit

Corporate company logo of Chimerix Inc (CMRX)

Chimerix, Inc. (CMRX) is focusing on completing the registration trials of ONC-201 for the therapy of rare brain neoplasms. The projected profit dynamics visualize these expectations, where the value of represents the most recent figure. The global expansion of the oncinidobulin pipeline should ensure the capture of the oncology market. However, high R&D costs and strict regulatory oversight create significant barriers to entry.

CMRX - Chimerix, Inc. Expected Net Income over the range 07/04/2022 - 11/14/2026

Analytical breakdowns for Chimerix, Inc (CMRX)

- share price and consensus valuation forecast:
Stock Price chimerix.com|CMRX - Analyst Consensus Forecast
- market capitalization data:
Market Value Chimerix Inc.|CMRX - Total Company Value
- company book value details:
Accounting Value per Share Chimerix|CMRX - Accounting Value of Company|Market Value to Book Value Ratio chimerix.com|CMRX - Company Assets
- debt and solvency information:
Debt to Equity Chimerix, Inc.|CMRX - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital chimerix.com|CMRX - Company Total Debt|Debt to Book Capitalization Ratio Chimerix|CMRX - Long-Term Debt|Company Short-Term Debt Chimerix|Quick Liquidity chimerix.com
- earnings and market ratios statistics:
CMRX - Company Net Income|Projected Future Earnings Chimerix, Inc.|CMRX - Market Cap to Net Income Ratio|Projected Price to Earnings chimerix.com|CMRX - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Chimerix, Inc|CMRX - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months Chimerix|CMRX - Earnings per share for the last four quarters|Quarterly EPS earnings growth chimerix.com|CMRX - Earnings per share increase in current year|Earnings growth forecast for next year Chimerix, Inc.
- sales and revenue indicators:
CMRX - Company Total Revenue|Company Projected Revenue Chimerix|CMRX - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple Chimerix, Inc.
Comprehensive company analysis:CMRX, Chimerix Inc
Core merchandise of Chimerix Inc.

The indicator aggregates market expectations for net income, updating data daily to eliminate reporting time gaps. An increase in the metric confirms fundamental stability, while a decrease signals business degradation. For Chimerix, Inc. (CMRX), this is critical, as production outsourcing minimizes capital expenditures. The efficiency of such a model is reflected in the trend of expected earnings. Analyze this consensus profit forecast chart to assess the risks of capital freeze.

Competitors of Chimerix, Inc.

INCY (incyte.com) - Projected Future Earnings|Expected Profit HCM|Expected Profit Nuvation Pharma (NUVB)|Expected Profit DAWN (Day One)|Monopar Therapeutics - Future Profit|Expected Net Income INBX|IMAB - Expected Profit|Expected Net Profit Fennec Pharma|Heron Therapeutics (HRTX) - Expected Profit|Net Profit Forecast NVCT|CHRS (Coherus BioSciences, Inc.) - Projected Future Earnings|Future Profit corbuspharma.com (CRBP)|Expected Profit Cardiff Oncology, Inc. (CRDF)|BYSI - Expected Net Profit|Expected Profit BioAtla Corp BCAB|Lixte Biotechnology, Inc. - Expected Profit|CTXR - Expected Profit|Expected Net Profit Cellectar Biosciences|BLRX: Projected Future Earnings|Projected Net Profit Can-Fite BioPharma, Ltd. CANF|Future Profit APRE|Expected Net Profit Kazia Therapeutics Limited KZIA|Future Profit SLXN (Silexion Therapeutics Corp.)|NCNA (NuCana Corp) - Expected Net Income|Cyclacel Pharmaceuticals - Future Profit|Future Net Profit GTHX (G1 Pharma)|Kronos Bio Corp - Projected Future Earnings|Expected Net Income KTRA (Kintara)|ONCT: Projected Future Earnings|Expected Net Profit portagebiotech.com (PRTG)